Pancreatic Cancer Research

ResearcherChongqing UniversityActive in the last 2 years

Jianyou Gu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0285-8919; OpenAlex author ID A5056363668. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 5

  1. The role of the aging process and related factor EMP1 in promoting progression of resectable pancreatic cancer. First author DOI 10.1016/j.gendis.2024.101490↗
  2. The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Co-author DOI 10.3389/fonc.2023.1138238↗
  3. Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway. Co-author DOI 10.3389/fonc.2023.1218781↗
  4. TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway. Co-author DOI 10.3389/fonc.2021.628353↗
  5. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription. Co-author DOI 10.7150/thno.44278↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huaizhi Wang · 5 shared papers, 2020–2025 · strength 0.75
  2. Shixiang Guo · 4 shared papers, 2020–2025 · strength 0.63
  3. Fuming Xie · 3 shared papers, 2020–2023 · strength 0.42
  4. Junfeng Zhang · 2 shared papers, 2021–2025 · strength 0.34
  5. Jingyang Yin · 2 shared papers, 2023 · strength 0.31
  6. Bojing Chi · 2 shared papers, 2023 · strength 0.31
  7. Wen Fu · 2 shared papers, 2023 · strength 0.31
  8. Rong Tang · 1 shared paper, 2025 · strength 0.22
  9. Xianxing Wang · 1 shared paper, 2021 · strength 0.12
  10. Yingfang Fan · 1 shared paper, 2021 · strength 0.12
  11. Liwei Zhu · 1 shared paper, 2021 · strength 0.12
  12. Tian Tao · 1 shared paper, 2021 · strength 0.12
  13. Songsong Liu · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.